# Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals - CNN

## Metadata
| Field | Value |
|-------|-------|
| Source | CNN |
| URL | https://news.google.com/rss/articles/CBMifEFVX3lxTE9MMFo1TkNWN3BuZE0xOXBXUEE1Ti1wcFZXMHRDUHhuQi1tVXpTVE9jWGI0ODJETlg1SFg0Q0lOUExCbVltZ1JqZFhlR1pYZk9SZlRjSzl3VFExQTdpR2c5cHg4RV9XSVZBbGR6bzVCb1dwQWlTS240MzE1bUw?oc=5&hl=en-US&gl=US&ceid=US:en |
| Scraped | 2025-12-30 12:05 |
| Category | GLP-1 |
| Relevance | 9/10 |
| Signal | bull |

## Investment Summary
White House negotiates Medicare coverage for obesity drugs at significantly reduced prices, potentially expanding market access and driving broader adoption of GLP-1 treatments.

## Key Entities
Medicare, Novo Nordisk, Eli Lilly, White House

## Dollar Amounts
$149

---

## Article Content

*Full content could not be extracted. Visit URL for details.*

---

#healthcare-news #glp-1 #auto-scraped
